Shomita Mandal

Shomita Mandal is an experienced professional in healthcare market insights and oncology commercial strategy, currently serving as the Senior Director of US Commercial Strategic Insights at Gilead Sciences since November 2021. With a robust background in market research, Shomita has successfully led teams at various leading organizations, including a self-employed consulting role from October 2019 to October 2021, where guidance was provided to companies during transitions. Prior roles include Global Marketing Director for Oncology Commercial Business Development at Amgen, and Senior Director of New Business Assessment at Pfizer. Shomita holds an MBA from Duke University and a Master's degree in Sociology from the University of Pennsylvania. Additionally, Shomita has contributed to the nonprofit sector as a board member for The Possibility Project.